Found: 3
Select item for more details and to access through your institution.
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1358573
- By:
- Publication type:
- Article
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium‐glucose cotransporter‐2 inhibitor and glucagon‐like peptide‐1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3248, doi. 10.1111/dom.15652
- By:
- Publication type:
- Article
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
- Published in:
- Diabetes & Vascular Disease Research, 2023, v. 20, n. 6, p. 1, doi. 10.1177/14791641231222837
- By:
- Publication type:
- Article